traditionally been highly recommended, is patient with intracranial pathology, undergoing cranioto my. In recent years, several clinical investigation.
of effects of N20 on cerebral. blood flow (CBF) intracranial pressure (ICP), cerebrospinal fluic (CSF) dynamics, sensory evoked potentials (SEPs). and pneumocephalus have been published. Results of these studies have mised the question: Should we continue to use N20 in neuroanesthesia? To answer this question, one first needs to examine the principles on which anesthetic management of patients with intracranial pathology should be based. Broadly speaking, these principles are as follows.
1. Prevent a rise of ICP during induction, because many of these patients have decreased intracranial compliance.
2. Provide a "shrunken brain" to facilitate surgical exposure, thus avoiding undue pressure during retraction, which may result in ischemic injury of underlying vital brain structures.
3. If electrophysiological monitoring (electroencephalogram/SEPs/facial nerve recordings) is being used, an anesthetic technique that causes the least interference with monitoring should be used.
4. Rapid emergence-thus allowing adequate neurological evaluation in the immediate postoperative period. It also allows early detection of neurological deterioration in the recovery room.
Next, one can make a decision about the place of N20 in achieving these goals in clinical practice based on the current knowledge of the effects of N20 in comparison to alternative choices. For the sake of. brevity we .will concentrate on published clinical studies only.
